Abstract
Our Objectives were (1) to compare lymphocyte subpopulation apoptosis rates in SSc patients versus healthy controls and (2) to compare Bcl-2 and NF-κB expression in cultured CD8 lymphocytes of SSc patients versus controls. Peripheral blood samples were obtained from 27 SSc patients meeting the American College of Rheumatology criteria for SSc and 28 healthy individuals. Mononuclear cells were isolated by Ficoll–Hypaque density gradient separation and cultured for 48 hr. For determination of apoptosis within specific cell populations, samples were labeled with PE-conjugated monoclonal antibody to CD8, CD4, and a FITC-conjugated monoclonal antibody to Annexin V. Flow cytometry was carried out with a FACS operating with Cellquest software. CD8+ lymphocytes were positively selected with magnetic microbeads conjugated to antihuman CD8. CD8 T cells were separated, then incubated with activation for 48 hr, and NF-κB and Bcl-2 analysis was carried out using Western immunoblotting. The CD4:CD8 ratio was increased in SSc compared to controls (2.6 ± 1.13 vs.1.87 ± 0.76; P = 0.018). The spontaneous apoptosis rate of SSc CD8 lymphocytes was increased compared to that of controls of (21.9 ± 13.7 vs. 13.3 ± 9.9; P = 0.019). No difference was found in the rate of CD4 apoptosis of SSc patients versus controls (9.8 ± 5.2 vs. 7.18 ± 4.89%; P = ns). The expression of NF-κB in SSc CD8 lymphocytes was decreased compared with that of CD8 lymphocytes from healthy controls (144 ± 13 vs. 188 ± 11; P = 0.018). Whereas expression of Bcl-2 was similar in activated CD8+ T cells of SSc patients and healthy controls, CD8+ T cell apoptosis rate was found to be in reverse correlation with expression of NFkB in these cells (r = −0.53, P = 0.029). The increased CD4:CD8 ratio in SSC may result from increased CD8+ T cell apoptosis. Increased SSc CD8 T cell apoptosis is associated with low levels of NF-κB.
Similar content being viewed by others
REFERENCES
LeRoy EC, Trojanowska M, Smith EA: The pathogenesis of scleroderma(systemic sclerosis, SSc). Clin Exp Rheumatol 9: 173-177, 1991
White B: Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 22: 695-708, 1996
Postlethwaite AE: A role of T cell and cytokines in effecting fibrosis. Int Rev Immunol 12: 247-258, 1995
Roumm AD, Whiteside TL, Medsger TA Jr, Rodnan GP: Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, sub-typing and clinical correlations. Arth Rheum 27: 645-653, 1984
Yurovsky VV, Wigley FM, Wise RA, White B: Skewing of the CD8+ T cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol 48: 84-97, 1996
Fiocco U, Rosada M, Cozzi L, et al.: Early phenotypic activation of circulating helper memory T cells in scleroderma: Correlation with disease severity. Ann Rheum Dis 52: 272-277, 1993
Gustafsson R, Totterman TH, Klareskog L, Hallgren R: Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 49: 40-45, 1990
Clements PJ, Peter JB, Agopian MS, Telian NS, Furst DE: Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effect of chlorambucil. J Rheumatol 17: 908-910, 1990
Kantor TV, Friberg D, Medsger TA Jr, Buckingham RB, Whiteside TL: Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol 65: 278-285, 1992
Whiteside TL, Kumagai Y, Roumm AD, Almendinger R, Rodnan GP: Suppressor cell function and T lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis. Arth Rheum 26: 841-847, 1983
Barnett AJ, Tait BD, Barnett MA, Toh BH: T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis). Clin Exp Immunol 76: 24-29, 1989
Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K Jr: Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin Immunol Immunopathol 56: 259-270, 1990
Dau PC, Callahan JP: Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs. Clin Immunol Immunopathol 70: 159-165, 1994
Freundlich B, Jimenez SA: Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: Activated T lymphocytes and the effect of D-penicillamine therapy. Clin Exp Immunol 69: 375-384, 1987
Keystone EC, Lau C, Galdman DD, Wilkinson S, Lee P, Shore A: Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol 48: 443-448, 1982
Stummvoll GH, Aringer M, Smolen JS, et al.: Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis. Rheumatology 39: 1341-1350, 2000
Subcommittee for Scleroderma Criteria of American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arth Rheum 23: 581-590, 1980
LeRoy EC, Black C, Fleischmajer R, et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202-205, 1988
Lanza L, Scudeletti M, Puppo F, et al.: Prednisone increase apoptosis in in vitro activated human peripheral blood T lymphocyte. Clin Exp Immunol 103: 482-490, 1996
Towbin H, Stachelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979
Lowry OH, Rosebrough NJ, Farr AL, Randall R: Protein measurement with the folin reagent. J Biol Chem 193: 265-275, 1951
Toubi E, Adir-Shani A, Kessel A, Shmuel Z, Sabo E, Hacham H: Immune aberrations in B and T lymphocytes derived from chronic urticaria patients. J Clin Immunol 20: 371-378, 2000
Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 6: 279-289, 1994
Vaishnaw AK, Mcnally JD, Elkon KB: Apoptosis in the rheumatic diseases. Arth Rheum 40: 1917-1927, 1997
Beg AA, Baltimore D: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784, 1996
Wang CY, Mayo MW, Baldwin AS Jr: TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787, 1996
Wu MX., Ao Z, Prasad KV, Wu R, Schlossman SF: IEX-IL, an apoptosis inhibitor involved in NF-[kappa]B-mediated cell survival. Science 281: 998-1001, 1998
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998
Tzeng E, Billiar TR, Williams DL, et al.: Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. Surgery 124: 278-283, 1998
Toubi E, Kessel A, Goldstein L, Slobodin G, Sabo E, Shmuel Z, Zuckerman E: Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity. J Hepatol 35: 774-780, 2001
Tamatani M, Che Y, Matsuzaki H, et al.: Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 274: 8531-8538, 1999
Zong WX, Edelstein LC, Chen C, Bash J, Gélinas C: The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kB that blocks TNFα-induced apoptosis. Genes Dev 13: 382-387, 1999
Wang CY, Guttridge DC, Mayo MW, Baldwin AS: NF-kB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19: 5923-5929, 1999
Wong KH, Kammer GA, Dennis G, Tsokos GC: Abnormal NF-kB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol 163: 1682-1689, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kessel, A., Rosner, I., Rozenbaum, M. et al. Increased CD8+ T Cell Apoptosis in Scleroderma Is Associated with Low Levels of NF-κB. J Clin Immunol 24, 30–36 (2004). https://doi.org/10.1023/B:JOCI.0000018060.36183.bb
Issue Date:
DOI: https://doi.org/10.1023/B:JOCI.0000018060.36183.bb